시너지이노베이션
048870KOSDAQ의료용 기기 제조업61.0 / 100
Reference Date: 2026-06-10
Company InformationBased on 2025 Annual Report
Business Overview
Synergy Innovation primarily manufactures and sells microbial culture media, produced in ISO13485 and KGMP-certified clean environments. In 2025, the company achieved total sales of 11.31 trillion KRW, with the medical sector contributing the largest share at 66.6%, followed by biotechnology (18.8%) and health functional food (12.4%). It operates through seven affiliated companies across biotechnology, medical devices, and health food sectors.
Number of Employees
65people
Average Salary
49.8M KRW
Score Calculation Basis
Detailed Financial Score
Lower than industry avg (good)
Half of industry avg (excellent)
Below industry avg
Lower than industry avg (good)
Avg ▲16.8% (2-year basis)
Avg ▲13.2% (2-year basis)
Avg ROE 5.4% (improving, 3yr)
Detailed News Sentiment
- Positive시너지이노베이션, 45억5000만원 규모 전환사채 소각
시너지이노베이션의 전환사채 소각 결정으로 재무 건전성이 강화되어 투자자 신뢰도 상승.
- Positive시너지이노베이션, 45.5억 CB 소각…"오버행 우려 차단"
시너지이노베이션의 CB 소각 결정으로 재무 건전성 강화 및 투자자 신뢰도 향상 기대.
- Neutral
Detailed Momentum
Near 52w low (3%, downtrend)
1m -13.37% (falling)
Volume flat
Detailed Disclosure
- Neutral기타경영사항(자율공시) (자기사채(제14회차 전환사채) 소각 결정의 건)2026-06-05
- Neutral주식등의대량보유상황보고서(일반)2026-05-21
- Neutral기업설명회(IR)개최2026-05-20
- Neutral분기보고서 (2026.03)2026-05-15
